Default
Allergy and immunology
Anaesthesia
Basic research
Cardiovascular medicine
Complementary medicine and alternative therapies
Critical care / intensive care
Dentistry / oral medicine
Dermatology
Emergency medicine
Endocrinology
Epidemiology
Ethics
Evidence-based medicine
Gastroenterology
Genetics
Geriatric medicine / aging
Haematology / blood transfusion
Health economics
Health policy
History of medicine
Infectious diseases
Internal medicine
Laboratory medicine
Legal and forensic medicine
Medical education
Medical informatics
Neurology
Nursing
Nutrition and metabolism
Obstetrics and gynaecology
Occupational and environmental medicine
Oncology
Ophthalmology
Organisation of health care
Otolaryngology / head and neck surgery
Paediatrics
Palliative care
Pathology
Patient-physician relationship
Pharmacology and therapeutics
Primary care, family medicine
Psychiatry and psychotherapy
Psychosomatics
Public health
Quality of care
Radiology
Rehabilitation medicine
Renal medicine
Respiratory medicine
Rheumatology
Sexual medicine
Sports medicine
Statistics and research methods
Surgery
Transplantation
Travel medicine
Urology
Use of SGLT2 inhibitors in cardiovascular diseases: why, when and how?
The authors present an up-to-date narrative literature review of the physiological mechanisms of action, current indications, therapeutic utility and side effects of SGLT2 inhibitors.
Effect of guideline revisions by the Swiss Society of Hypertension on blood pressure control in hypertensive patients from primary care
The 2009 guideline change in high-risk patients was associated with a reduction in systolic office blood pressure together with an increase in pharmacological combination therapy. These results highlight primary care physicians’ efforts to implement blood pressure guidelines. Further, blood pressure goal attainment was more likely to be achieved in later follow-up visits.
Coronary and structural heart interventions in Switzerland 2018
Since 1987, based on a standardised questionnaire that has evolved over the years, all Swiss cardiology centres are asked to report yearly aggregate data on the number and type of percutaneous cardiac procedures performed.
Marfan syndrome and related connective tissue disorders in the current era in Switzerland in 103 patients: medical and surgical management and impact of genetic testing
Marfan syndrome (MFS) and related connective tissue disorders (CTDs) are increasingly recognised. Genetic testing has greatly improved the diagnostic outcome/power over the last two decades.
Atrial fibrillation for internists: current practice
Atrial fibrillation is the most common sustained cardiac arrhythmia in clinical practice, and its prevalence is expected to increase in the near future.
Plaque vulnerability in patients with high- and moderate-grade carotid stenosis – comparison of plaque features on MRI with histopathological findings
Plaque vulnerability plays an important role in determining the risk of subsequent cerebrovascular events in patients with carotid stenosis. Plaque morphology magnetic resonance imaging (MRI) can be used to assess plaque vulnerability.
Fiftieth anniversary of the first heart transplantation in Switzerland in the context of the worldwide history of heart transplantation
To commemorate the 50th anniversary of the first heart transplantation in Switzerland, on 14 April 1969, this article reviews the history of the procedure worldwide and current challenges.
Duration of pharmacological thromboprophylaxis after outpatient endovenous laser ablation: a propensity score-matched analysis
Many centres in Europe, including several in Switzerland, use pharmacological thromboprophylaxis after thermal ablation of varicose veins. However, the optimal duration of pharmacological thromboprophylaxis is currently not defined.
Role of imaging in primary prevention: calcium score is a robust and cost-efficient risk modifier
Subclinical atherosclerosis, assessed by imaging, is associated with outcome. Imaging has the potential to enable providers to better tailor preventive therapy towards patient risk stratification compared to traditional risk scores.
First in Switzerland: concomitant off-pump transapical transcatheter aortic valve implantation and mitral valve reconstruction with the NeoChord system
Older and polymorbid patients with multivalvular heart disease exhibit high perioperative morbidity and mortality when treated with conventional surgery. Minimally invasive concomitant procedures are, however, possible.
